Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Novartis updates on uses and safety of Beovu in patients with wet AMD

      Novartis updates on uses and safety of Beovu in patients with wet AMD

      Medical Dialogues Bureau3 March 2020 10:00 AM IST
      If clinical signs of intraocular inflammation or changes in vision after Beovu injection are observed doctor should perform the appropriate diagnostic...
      Ficci calls for preventive measures of coronavirus in India

      Ficci calls for preventive measures of coronavirus in India

      Medical Dialogues Bureau3 March 2020 9:00 AM IST
      New Delhi: Industry body Ficci has recently called for measures to prevent the spread of deadly coronavirus in India, even as two more cases -- one in...
      Sanofi to pay USD 11.9 million to resolve US drug charity kickback probe

      Sanofi to pay USD 11.9 million to resolve US drug charity kickback probe

      Medical Dialogues Bureau2 March 2020 12:05 PM IST
      Sanofi SA has agreed to pay $11.85 million to resolve U.S. allegations that it used a charity that helps cover Medicare patients' out-of-pocket drug...
      Dr VG Somani DCGI releases IPA guidelines on Market Complaints.

      Dr VG Somani DCGI releases IPA guidelines on Market Complaints.

      Medical Dialogues Bureau2 March 2020 10:30 AM IST
      The guidelines were released at the recently concluded India Pharmaceutical Forum
      Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

      Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

      Medical Dialogues Bureau2 March 2020 10:15 AM IST
      San Diego: Illumina, Inc. today announced that it has filed a patent infringement suit relating to BGI's "CoolMPS" sequencing products. The complaint...
      Philips, European Society of Radiology to host Ultrasound Academy at ECR 2020

      Philips, European Society of Radiology to host Ultrasound Academy at ECR 2020

      Medical Dialogues Bureau2 March 2020 9:00 AM IST
      Amsterdam and Vienna: Royal Philips a global leader in health technology, and the European Society of Radiology (ESR), have announced a collaboration...
      COVID-19: USFDA updates about supply chain effect on medicines, devices and PPE

      COVID-19: USFDA updates about supply chain effect on medicines, devices and PPE

      Medical Dialogues Bureau1 March 2020 2:45 PM IST
      A manufacturer has alerted that a shortage of a human drug that was recently added to the drug shortages list.
      FDA Advisory approves Lillys CYRAMZA (ramucirumab) for type of lung Cancer

      FDA Advisory approves Lilly's CYRAMZA (ramucirumab) for type of lung Cancer

      Medical Dialogues Bureau1 March 2020 2:00 PM IST
      The ODAC considered the safety and efficacy data from the Phase 3 RELAY trial, which is the basis for the CYRAMZA supplemental Biologics License...
      Biohaven Receives Fda Approval for acute migraine drug

      Biohaven Receives Fda Approval for acute migraine drug

      Medical Dialogues Bureau1 March 2020 12:30 PM IST
      A single quick-dissolving tablet of NURTEC ODT can provide fast pain relief and return patients to normal function within one hour, and deliver...
      Meril Life Sciences gets 5 years exemption from NPPA for its MeRes100 stent

      Meril Life Sciences gets 5 years exemption from NPPA for its MeRes100 stent

      Medical Dialogues Bureau1 March 2020 11:00 AM IST
      New Delhi: The national pharmaceutical regulator NPPA has exempted a new coronary stent developed by Meril Life Sciences from price control for five...
      Merck, AMCM collaborates for 3D Printing of Tablets

      Merck, AMCM collaborates for 3D Printing of Tablets

      Medical Dialogues Bureau1 March 2020 10:30 AM IST
      3D printing allows for API (active pharmaceutical development) formulation to be scalable while avoiding costly reformulations throughout the entire...
      Sandoz commits to keep prices of essential medicines stable amidst coronavirus fear

      Sandoz commits to keep prices of essential medicines stable amidst coronavirus fear

      Medical Dialogues Bureau1 March 2020 10:00 AM IST
      Germany: Sandoz the provider of off-patent antibiotic medicines worldwide, made a public commitment to ensure stable pricing for a basket of essential...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok